Mandate

Vinge advises FSN Capital L.P. II et al. on divestment of the CTEK/Creator Group

June 09, 2011

Vinge is advising FSN Capital L.P. II et al. in connection with the divestment of the CTEK/Creator Group to Altor Fund III.

The CTEK/Creator group is the world’s premier manufacturer of advanced battery chargers, sold under inter alia the "CTEK" brand, and a provider of consulting services related to product development under the “Creator” brand. CTEK is, in addition to sales under its own brand, delivering battery chargers to well renowned brands such as Rolls Royce, Ferrari, Porsche, Bentley, Mercedes-Benz, BMW, Lexus, Lamborghini, Alfa Romeo, Audi, Corvette, Maserati, Scania and Yamaha.

Since the investment by FSN Capital L.P. II in April 2008, CTEK has experienced largely increased sales volumes as well as a largely increased EBITDA despite having made significant investments in sales & marketing, R&D and the overall organization.

Closing of the transaction is subject to applicable competition law approvals.

The Vinge team advising FSN Capital L.P. et al. includes partners Bo Adrianzon and Johan Göthberg and inter alia associates Johan Steen, Carolina Walther and Ulrich Ziche.

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised EQT managed Scaleup Europe Fund on its investment in Tandem Health

Vinge has advised EQT managed Scaleup Europe Fund as lead investor in Tandem Health's USD 100 million Series B investment round, with participation from existing investors Kinnevik, Northzone, Amino Collective and Visionaries. Tandem Health is an AI healthcare company founded in 2023 and headquartered in Sweden. Tandem Health operates as an AI partner within the healthcare sector across Europe, providing AI medical assistant support to clinicians in connection with patient visits.
September 15, 2026